Anzeige
❌
Mehr »
Dienstag, 20.10.2026 - Börsentäglich über 12.000 News
Lithium vor 2022. Kernkraft vor dem Comeback. Tiefseebergbau jetzt!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
191 Leser
Artikel bewerten:
(0)

ZeOmega Launches Jiva PrudenceAI to Embed Governed AI in Daily Health Plan Operations

New intelligence platform brings AI applications, customer-approved models and unified member data directly into utilization and care management workflows

PLANO, TX / ACCESS Newswire / October 20, 2026 / ZeOmega, the industry's leading population health management organization, today announced the launch of Jiva PrudenceAI, an AI intelligence and orchestration platform for health plans and other risk-bearing organizations. Jiva PrudenceAI adds an intelligence layer over healthcare management platforms, including Jiva, delivering summaries, recommendations, and prepared actions inside the workflows utilization management (UM) and care management (CM) teams already use. Built-in governance controls which AI models run, what each one can do, how outputs are validated, and when clinicians review decisions.

Health plans face growing authorization volumes, mounting care manager workloads, and rising expectations from members, providers, and regulators, all while being asked to do more with the same resources. AI holds promise to relieve that pressure, but too often it arrives as a disconnected tool working from incomplete data, with little visibility into how its recommendations are made.

Jiva PrudenceAI is designed to close that gap by bringing data, intelligence, and governance together where work actually gets done. By automating manual work, it accelerates decisions and expands staff capacity, helping reduce the cost of each prior authorization, shorten turnaround times, and ease the documentation burden behind care manager overtime and attrition.

"Health plans don't need to migrate platforms to put AI to work. They need an AI foundation they can trust and without being forced to investing in new AI native platforms," said Sam Rangaswamy, CEO, ZeOmega. "For more than two decades, we have supported health plans' clinical records and care operations, and Jiva PrudenceAI builds on that experience. Plans can use AI from ZeOmega, their own models, or a certified partner, all under the same controls. That combination of intelligence and governance is what payers are asking for right now."

Key Jiva PrudenceAI capabilities include:

  • Prior authorization support: Smart UM automates authorization intake, including faxes, and assists reviewers with medical guidelines, digitized health plan policies, and decision support.
  • Care management support: Prepares care managers for member calls, summarizes calls and clinical information, recommends assessments, and drafts care plans.
  • A complete view of each member: The Jiva Data Fabric brings together clinical, operational, administrative, and external data, along with risk scores, chronic conditions, and case context for real time risk stratification analysis and a real-time view of each member. It runs on a hybrid cloud lakehouse.
  • Oversight of every AI action: Logs, explains, and can halt any AI-driven decision in real time, with full audit trails and human review. Member health information remains within ZeOmega's secure environment.
  • Flexibility to add AI: Health plans can choose ready-to-use applications from ZeOmega's catalog, connect their own approved AI models through bring-your-own-AI (BYoAI) interfaces, or integrate tools from ZeOmega's certified partners.

ZeOmega's approach to AI governance has been independently validated. In July 2026, the company earned Artificial Intelligence Accreditation from DirectTrust, which recognizes AI governance, risk management, and oversight practices aligned with the National Institute of Standards and Technology (NIST) AI Risk Management Framework.

"In healthcare, it is not about the latest model. It is about the trusted one," said Jeff Rush, Chief AI Officer, ZeOmega. "We built Jiva PrudenceAI so that every AI action, no matter which model produced it, runs under the same policies, the same validation, and the same human review. Governance is not a feature we added on top of the product, it is the architecture the product was built on."

Jiva PrudenceAI is available now. Health plans can deploy it alongside the utilization and care management systems already in use, without switching platforms, and existing ZeOmega Jiva clients can activate it directly. To learn more or request a demo, visit Jiva PrudenceAI: AI Orchestration for Health Plans | ZeOmega or contact sales@zeomega.com.

About ZeOmega

ZeOmega empowers health plans and other risk-bearing organizations with the industry's leading technology for simplifying population health management. Clients using ZeOmega's Jiva Healthcare Enterprise Management Platform experience superior workflow and proven results due to exceptional integration capabilities, unmatched clinical content, and a powerful rules engine. With deep domain expertise and a comprehensive understanding of population health challenges, ZeOmega serves as a true partner for clients with personalized deployment and delivery models. By consistently exceeding customer expectations and project benchmarks, ZeOmega has earned a reputation for being proactive, reliable, and dedicated to improving the health of its clients' members. ZeOmega was named Best in KLAS for Payer Care Management Solutions in 2022, 2023, 2024, and 2025. Founded in 2001, ZeOmega is privately held and headquartered in Plano, Texas.

ZeOmega and Jiva are registered trademarks or trademarks of ZeOmega, Inc. or its subsidiaries in the United States and other countries. Other marks or brands may be claimed as the property of others.

Media Contact:

Karina Stabile
Aria Marketing for ZeOmega
KStabile@ariamarketing.com

SOURCE: ZeOmega



View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/zeomega-launches-jiva-prudenceai-to-embed-governed-ai-in-daily-health-1238881

© 2026 ACCESS Newswire
KI-Euphorie kippt - Bei diesen 5 Aktien droht der Crash!
Drei Jahre lang kannten KI-Aktien fast nur eine Richtung: nach oben. Billionenschwere Investitionspläne von Alphabet, Amazon, Meta und Microsoft haben Halbleiter- und Infrastrukturwerte auf immer neue Höhen getrieben. Doch jetzt bekommt die Erfolgsstory gefährliche Risse.

Steigende Anleiherenditen verteuern die Finanzierung, während die gewaltigen KI-Ausgaben zunehmend nicht mehr aus den laufenden Cashflows bezahlt werden können. Gleichzeitig zeigen günstigere chinesische Modelle, dass leistungsfähige KI womöglich mit deutlich weniger Rechenleistung auskommt. Damit wächst die Gefahr, dass heute für Milliarden errichtete Kapazitäten morgen nicht die erhofften Renditen liefern.

Für Anleger könnte das zum Problem werden. Denn treffen steigende Finanzierungskosten auf Überkapazitäten und enttäuschende Cashflows, geraten gerade hoch bewertete KI-Profiteure schnell unter Druck. Aus den größten Gewinnern der vergangenen Jahre könnten so die größten Verlierer der nächsten Korrektur werden.

In unserem aktuellen Spezialreport zeigen wir 5 Aktien, bei denen das Chance-Risiko-Verhältnis jetzt besonders gefährlich erscheint – und bei denen Anleger genauer hinschauen sollten.

Jetzt den kostenlosen Report sichern – bevor die KI-Euphorie ihren nächsten Realitätstest erlebt!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.